Page 153 - 2023 Taiwan Health and Welfare Report
P. 153

12                                                                               Research, Development, and      12
                                                                                      International Cooperation




                  6. Improved Healthcare Systems                       for COVID-19 inspection and verification when
                    (1)  Completed the analysis of our country's integrated   citizens travel abroad.
                       inpatient care service model and certification   8. Established a Model for Diverting Child and
                       systems for nursing assistant and clinical nurse   Adolescent Reporting Cases
                       educator. This serves as a reference for the pilot   Utilizing AI and machine learning techniques, we
                       program of comprehensive health insurance    integrated the network service information to
                       integrated inpatient care services, enhancing the   establish an evidence-based model for diverting
                       quality of inpatient care and reducing the workload   child and youth reporting cases. By incorporating
                       in the nursing profession.                   qualitative guidance for child and adolescent
                    (2)  Establish standards, mechanisms and examples   diversion, we aimed to assign cases to the most
                       of pre-established medical processes for nurse   appropriate service system, ensuring timely
                       practitioners, organize 20 training workshops,   provision of supportive and protective services to
                       and finalize local pre-established medical   individuals, while reducing the workload of social
                       processes training materials for reference and   workers involved in case screening and assignment.
                       application in hospitals to improve the quality of
                                                                  Section 2  Developing Innovative and
                       care for nurse practitioners and patient safety.
                                                                              Translational Research
                  7. Prevention and Control of Infectious Diseases
                                                                  1. Technology patent licensing
                    (1)  Developed a rapid diagnostic system for Japanese
                       encephalitis virus that exhibits better sensitivity   (1)  Successfully transferring research outcomes
                       and specificity performance than the currently   through technological transfer in 2022, the
                       available commercial rapid reagents. Additionally,   technology is named as follows:
                       we  have  effectively  utilized  the  BIOFIRE®   National Research Institute of Chinese Medicine
                       Filmarray Respiratory 2.1 plus Panel tests to   102(NRICM102)
                       detect cases of unidentified infectious diseases.   (2)  The total income from research and development
                       Established standardized AI-based epidemic      results was NTD 9,128,108 in 2022, as shown in
                       prevention demonstration sites in remote tribal   Figure 12-1.
                       areas, interconnected with the National Center
                                                                  2. Responding to COVID-19 Pandemic
                       for High-Performance Computing, to monitor and
                                                                    (1)  Stable R&D Group of Central Epidemic
                       analyze the correlation between air quality and
                                                                       Command Center and Technical Support
                       infectious diseases.
                                                                       Platform Operations
                    (2)  Created a surveillance panel for avian influenza
                                                                       A. President Liang, Kung-Yee led the R&D group
                       outbreaks for both domestic and international,
                                                                         to continue inspecting the domestic and
                       incorporating automated statistical and visual
                                                                         international pandemic prevention experience,
                       analysis functions to  enhance  the  integrity
                                                                         and provided foresighted thinking on applying
                       and timeliness of epidemic monitoring data.
                                                                         technology to epidemic prevention for the
                       Established a network platform for comparing
                                                                         government policy making.
                       pathogen data of Campylobacter in real-time,
                       aligning with the prevention and control of     B. Supportive platform for developing SARS-
                       zoonotic diseases and enabling swift assessment   CoV-2 screening and analytics techniques:
                       of the scale of outbreaks.                        Matching was conducted to provide institutes
                                                                         with technical supporting for their preclinical
                    (3)  Optimized the code management, remote
                                                                         testing, thereby creating a trigger mechanism
                       backup, and overall cybersecurity protection of
                                                                         for specimen applications.
                       the disease control agency. Added integration
                       with the "Digital COVID-19 Certificate Issuance   C. COVID-19 Biobank: Blood specimens
                       Platform" to access the "COVID-19 Testing Data"   and clinical data were offered for epidemic
                       dataset, facilitating compliance with regulations   prevention R&D. TFDA used the sources to



 150                                                                                                             151
   148   149   150   151   152   153   154   155   156   157   158